European Heart Journal




One-year access to more than 500 world journals available in the system
    http://medilib.ir
  • Duration of Time : 365 Day
  • Price : 300$
  • Special Price : 100$
Order

The growing role of genetics in the understanding of cardiovascular diseases: towards personalized medicine 

Filippo Crea

doi : 10.1093/eurheartj/ehab279

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Pages 1929–1933,

Buy The Package and View The Article Online


Broaden your horizons with the latest addition to the journal family, EHJ Open

Judith Ozkan

doi : 10.1093/eurheartj/ehab203

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Pages 1934–1935,

Buy The Package and View The Article Online


Powerful tributes to pioneering cardiologist Bernard Lown

Mark Nicholls

doi : 10.1093/eurheartj/ehab178

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Pages 1935–1936,

Buy The Package and View The Article Online


Cardiovascular Genetics in the European Heart Journal

Andros Tofield

doi : 10.1093/eurheartj/ehaa705

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Page 1937,

Buy The Package and View The Article Online


A most remarkable person: Dr Bernard Lown

Peter Russell Kowey

doi : 10.1093/eurheartj/ehab202

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Pages 1938–1939,

Buy The Package and View The Article Online


Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies

Nazha Hamdani, Sarah Costantino, Andreas Mügge, Djamel Lebeche, Carsten Tsch?pe

doi : 10.1093/eurheartj/ehab197

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Pages 1940–1958,

Described as the ‘single largest unmet need in cardiovascular medicine’, heart failure with preserved ejection fraction (HFpEF) remains an untreatable disease currently representing 65% of new heart failure diagnoses.

Buy The Package and View The Article Online


Genetic insight into sick sinus syndrome

Rosa B Thorolfsdottir, Gardar Sveinbjornsson, Hildur M Aegisdottir, Stefania Benonisdottir, Lilja Stefansdottir

doi : 10.1093/eurheartj/ehaa1108

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Pages 1959–1971,

The aim of this study was to use human genetics to investigate the pathogenesis of sick sinus syndrome (SSS) and the role of risk factors in its development.

Buy The Package and View The Article Online


Genetic insight into sick sinus syndrome. Is there a pill for it or how far are we on the translational road to personalized medicine?

Philipp Tomsits, Sebastian Clauss, Stefan K??b

doi : 10.1093/eurheartj/ehab209

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Pages 1972–1975,

Buy The Package and View The Article Online


Association between prophylactic angiotensin-converting enzyme inhibitors and overall survival in Duchenne muscular dystrophy—analysis of registry data

Raphaël Porcher, Isabelle Desguerre, Helge Amthor, Brigitte Chabrol, Frédérique Audic

doi : 10.1093/eurheartj/ehab054

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Pages 1976–1984,

To estimate the effect of prophylactic angiotensin-converting enzyme inhibitors (ACEi) on survival in Duchenne muscular dystrophy (DMD).

Buy The Package and View The Article Online


Cardioprotection in Duchenne muscular dystrophy

Anjali Tiku Owens, Mariell Jessup

doi : 10.1093/eurheartj/ehab152

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Pages 1985–1987,

Buy The Package and View The Article Online


Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy

Nicholas A Marston, Larry Han, Iacopo Olivotto, Sharlene M Day, Euan A Ashley

doi : 10.1093/eurheartj/ehab148

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Pages 1988–1996,

Childhood-onset hypertrophic cardiomyopathy (HCM) is far less common than adult-onset disease, thus natural history is not well characterized. We aim to describe the characteristics and outcomes of childhood-onset HCM.

Buy The Package and View The Article Online


Childhood-onset hypertrophic cardiomyopathy research coming of age

Juan Pablo Kaski

doi : 10.1093/eurheartj/ehab093

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Pages 1997–1999,

Buy The Package and View The Article Online


Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23

Sophie Garnier, Magdalena Harakalova, Stefan Weiss, Michal Mokry, Vera Regitz-Zagrosek

doi : 10.1093/eurheartj/ehab030

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Pages 2000–2011,

Our objective was to better understand the genetic bases of dilated cardiomyopathy (DCM), a leading cause of systolic heart failure.

Buy The Package and View The Article Online


Genome-wide association for heart failure: from discovery to clinical use

Dominic E Fullenkamp, Megan J Puckelwartz, Elizabeth M McNally

doi : 10.1093/eurheartj/ehab172

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Pages 2012–2014,

Buy The Package and View The Article Online


Influenza vaccination: a ‘shot’ at INVESTing in cardiovascular health

Ankeet S Bhatt, Orly Vardeny, Jacob A Udell, Jacob Joseph, KyungMann Kim …

doi : 10.1093/eurheartj/ehab133

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Pages 2015–2018,

The link between viral respiratory infection and non-pulmonary organ-specific injury, including cardiac injury, has become increasingly appreciated during the current coronavirus disease 2019 (COVID-19) pandemic.

Buy The Package and View The Article Online


Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation

Paolo Verdecchia, Fabio Angeli, Claudio Cavallini

doi : 10.1093/eurheartj/ehaa906

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Page 2019,

Buy The Package and View The Article Online


Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation – Dual versus triple antithrombotic therapy

Jean-Philippe Collet, Holger Thiele

doi : 10.1093/eurheartj/ehaa909

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Pages 2020–2021,

Buy The Package and View The Article Online


A bleeding Blalock–Taussig shunt

Chia-Yi Chin, Shu-Chien Huang, Jou-Kou Wang, Chun-An Chen

doi : 10.1093/eurheartj/ehaa887

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Page 2022,

Buy The Package and View The Article Online


Percutaneous transmyocardial ablation of a metastatic adrenocortical carcinoma invading the interventricular septum

Xudong Xie, Yijiang Zhou, Bifeng Wu, Xiaogang Guo

doi : 10.1093/eurheartj/ehaa911

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Page 2023,

Buy The Package and View The Article Online


Corrigendum to: Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23

doi : 10.1093/eurheartj/ehab192

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Page 2011,

Buy The Package and View The Article Online


Anticoagulation, atherothrombosis, and heart failure: lessons from COMMANDER-HF and CORONA

Simon A S Beggs, Pardeep S Jhund, John J V McMurray

doi : 10.1093/eurheartj/ehy609

European Heart Journal, Volume 42, Issue 20, 21 May 2021, Pages e5–e7,

Buy The Package and View The Article Online


Do you want to add Medilib to your home screen?